Clinical Trial Update: A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia [Phase 1]

View source ↗

Summary

Phase 1 safety study of the investigational agent BMS-852927 in adults with hypercholesterolemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• BMS-852927

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hypercholesterolemia | Phase 1 | Status: TERMINATED